CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Koa Shoji Holdings Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Koa Shoji Holdings Co Ltd
7-13-15, Hiyoshi, Kohoku-ku
Phone: +81 455606607p:+81 455606607 YOKOHAMA-SHI, KNG  223-0061  Japan Ticker: 92739273
Business Summary
KOA SHOJI HOLDINGS CO., LTD. is engaged in purchasing and sales of drug substance, manufacturing, purchasing and sales of pharmaceuticals, including medical prescription drugs and general pharmaceutical products, as well as contract manufacturing of formulation of pharmaceuticals. The Company operates through two business segments. The pharmaceutical manufacturing and sales business is engaged in development, manufacturing, contract manufacturing and sales of generic injection, oral preparation and external preparation. The drug substance sales business is engaged in import and export of generic drug raw materials, as well as introducing and supply of pharmaceutical raw materials and preparations.
(Source: N-30D)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20236/30/2023Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chairman of Subsidiaries, Representative Director ToshiyukiShuto 71 9/1/2021 1/1/2015
President of Subsidiary, Director ToshihiroHirono 73 9/1/2018 1/1/2015
Senior Managing Director ToshinoriKoyama 74 9/1/2016 1/1/2015
7 additional Officers and Directors records available in full report.

Business Names
Business Name
9273
KOA BIOTECH BAY CO., LTD.
KOA ISEI CO., LTD.
KOA PHARMACEUTICAL CO., LTD.
KOA SHOJI CO., LTD.

General Information
Number of Employees: 297 (As of 6/30/2023)
Outstanding Shares: 39,618,624 (As of 12/31/2023)
Shareholders: 23,596
Stock Exchange: TYO


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024